Fascia iliaca block prophylaxis for hip fracture patients at risk for delirium: a randomized placebo-controlled study.
BACKGROUND
Recent studies have indicated that unmanaged pain, both acute and chronic, can affect mental status and might precipitate delirium, especially in elderly patients with hip fractures. The aim of this study was to assess the effectiveness of fascia iliaca compartment block (FICB) for prevention of perioperative delirium in hip surgery patients who were at intermediate or high risk for this complication.


METHODS
On admission, all included patients were divided into three groups according to low, intermediate or high risk for perioperative delirium. Eligible patients (those classified as at intermediate or high risk for developing delirium) were sequentially randomly assigned to study treatment (FICB prophylaxis or placebo) according to a computer-generated randomization code. The primary outcome was perioperative delirium. Diagnosis of the syndrome was defined using the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) and Confusion Assessment Method (CAM) criteria. Secondary outcome variables were severity of delirium and delirium duration.


RESULTS
Delirium occurred in 33 (15.94%) out of 207 patients randomized to FICB prophylaxis or the placebo group. Incidence of delirium in the FICB prophylaxis group was 10.78% (11/102), significantly different from the incidence (23.8%, 25/105) in the placebo group [relative risk 0.45, 95% confidence interval (CI) 0.23-0.87]. Nine of 17 patients with high risk for delirium and included in the FICB prophylaxis group developed delirium, whereas 10 of 16 high-risk patients included in the placebo group became delirious (relative risk 0.84, CI 0.47-1.52). Two of 85 patients with intermediate risk for delirium and included in the FICB prophylaxis group developed delirium, whereas 15 of 89 intermediate-risk patients included in the placebo group became delirious (relative risk 0.13, CI 0.03-0.53). Severity of delirium according to the highest value of the DRSR-98 during an episode with delirium in patients in the FICB prophylaxis group was on average 14.34, versus 18.61 in the placebo group (mean difference 4.27, 95% CI 1.8-5.64, P < 0.001). Mean duration of delirium in the FICB prophylaxis group was significantly shorter than in the placebo group (FICB 5.22 days versus placebo 10.97 days, 95% CI 3.87-7.62, P < 0.001).


CONCLUSIONS
No significant difference was found among high-risk patients between FICB prophylaxis and placebo groups in terms of delirium incidence. However, FICB prophylaxis significantly prevented delirium occurrence in intermediate-risk patients. Thus FICB prophylaxis could be beneficial, particularly for intermediate-risk patients.
Mouzopoulos
George
G
Orthopaedic Department, Evangelismos Hospital, Athens, Greece. gmouzopoulos@yahoo.gr
Vasiliadis
George
G
Lasanianos
Nikolaos
N
Nikolaras
George
G
Morakis
Emanouil
E
Kaminaris
Michalis
M
D000368:Aged; D000779:Anesthetics, Local / Q000008:administration & dosage; D002045:Bupivacaine / Q000008:administration & dosage; D003693:Delirium / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005593:Fracture Fixation, Internal / Q000009:adverse effects; D006620:Hip Fractures / Q000150:complications / Q000601:surgery*; D006801:Humans; D008297:Male; D009407:Nerve Block / Q000379:methods*; D010146:Pain / Q000209:etiology / Q000517:prevention & control*; D019990:Perioperative Care / Q000379:methods*; D011446:Prospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000779:Anesthetics, Local; D002045:Bupivacaine
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
Am J Med. 1994 Sep;97(3):278-88
8092177
JAMA. 1994 Jan 12;271(2):134-9
8264068
JAMA. 1996 Mar 20;275(11):852-7
8596223
Br J Anaesth. 2003 Jan;90(1):53-7
12488379
Ann Emerg Med. 2002 Mar;39(3):248-53
11867976
J Psychiatr Res. 1982-1983;17(1):37-49
7183759
J Am Geriatr Soc. 2001 May;49(5):523-32
11380743
Psychol Forsch. 1954;24(4):349-57
13204500
Injury. 1994 May;25(4):237-9
8206656
Age Ageing. 1999 Mar;28(2):115-9
10350406
Pain. 1997 Apr;70(2-3):149-54
9150288
Ann Intern Med. 1990 Dec 15;113(12):941-8
2240918
J Am Geriatr Soc. 1994 Aug;42(8):809-15
8046190
Md State Med J. 1965 Feb;14:61-5
14258950
J Neuropsychiatry Clin Neurosci. 2000 Winter;12(1):51-6
10678513
Anesthesiology. 2007 Apr;106(4):773-8
17413915
J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):76-81
12560416
Psychiatry Res. 1988 Jan;23(1):89-97
3363018
Anesth Analg. 1989 Dec;69(6):705-13
2589650
J Emerg Med. 2007 Apr;32(3):257-62
17394987
Injury. 2005 Apr;36(4):505-10
15755432
Crit Care Med. 1985 Oct;13(10):818-29
3928249
Ann Intern Med. 1993 Sep 15;119(6):474-81
8357112
J Am Geriatr Soc. 2001 May;49(5):516-22
11380742
Ann Emerg Med. 2002 Mar;39(3):338-41
11867994
Semin Clin Neuropsychiatry. 2000 Apr;5(2):75-85
10837096